109 related articles for article (PubMed ID: 11756946)
21. Risk of second primary malignancies following cutaneous melanoma diagnosis: a population-based study.
Spanogle JP; Clarke CA; Aroner S; Swetter SM
J Am Acad Dermatol; 2010 May; 62(5):757-67. PubMed ID: 20223559
[TBL] [Abstract][Full Text] [Related]
22. Risk of non-Hodgkin's lymphoma and family history of lymphatic, hematologic, and other cancers.
Chatterjee N; Hartge P; Cerhan JR; Cozen W; Davis S; Ishibe N; Colt J; Goldin L; Severson RK
Cancer Epidemiol Biomarkers Prev; 2004 Sep; 13(9):1415-21. PubMed ID: 15342441
[TBL] [Abstract][Full Text] [Related]
23. Advances in the epidemiology of HIV-associated non-Hodgkin's lymphoma and other lymphoid neoplasms.
Franceschi S; Dal Maso L; La Vecchia C
Int J Cancer; 1999 Nov; 83(4):481-5. PubMed ID: 10508483
[TBL] [Abstract][Full Text] [Related]
24. Incidence and epidemiology of non-Hodgkin lymphoma and risk of second malignancy among 22 466 survivors in Israel with 30 years of follow-up.
Tadmor T; Liphshitz I; Silverman B; Polliack A
Hematol Oncol; 2017 Dec; 35(4):599-607. PubMed ID: 27238496
[TBL] [Abstract][Full Text] [Related]
25. Epstein-Barr virus-associated extranodal non-Hodgkin's lymphoma of the sinonasal tract and nasopharynx in Thailand.
Mitarnun W; Suwiwat S; Pradutkanchana J
Asian Pac J Cancer Prev; 2006; 7(1):91-4. PubMed ID: 16629523
[TBL] [Abstract][Full Text] [Related]
26. Hodgkin's disease following non-Hodgkin's lymphoma.
Travis LB; Gonzalez CL; Hankey BF; Jaffe ES
Cancer; 1992 May; 69(9):2337-42. PubMed ID: 1562981
[TBL] [Abstract][Full Text] [Related]
27. Increased incidence of non-Hodgkin's lymphoma in inflammatory bowel disease patients on immunosuppressive therapy but overall risk is low.
Farrell RJ; Ang Y; Kileen P; O'Briain DS; Kelleher D; Keeling PW; Weir DG
Gut; 2000 Oct; 47(4):514-9. PubMed ID: 10986211
[TBL] [Abstract][Full Text] [Related]
28. Incidence of non-Hodgkin's lymphoma in patients treated for Hodgkin's disease.
Prósper F; Robledo C; Cuesta B; Rifón J; Borbolla JR; Pardo J; Rocha E
Leuk Lymphoma; 1994 Feb; 12(5-6):457-62. PubMed ID: 8180608
[TBL] [Abstract][Full Text] [Related]
29. Cutaneous Melanoma, Hodgkin's Lymphoma and non-Hodgkin's Lymphoma: Common Risk Factors?
Allam MF; Serrano PF; Serrano JL; Abd Elaziz KM; Del Castillo AS; Navajas RF
Cent Eur J Public Health; 2015 Jun; 23(2):119-21. PubMed ID: 26851421
[TBL] [Abstract][Full Text] [Related]
30. Non-Hodgkin's lymphoma of the gastrointestinal tract: a population-based analysis of incidence, geographic distribution, clinicopathologic presentation features, and prognosis. Danish Lymphoma Study Group.
d'Amore F; Brincker H; Grønbaek K; Thorling K; Pedersen M; Jensen MK; Andersen E; Pedersen NT; Mortensen LS
J Clin Oncol; 1994 Aug; 12(8):1673-84. PubMed ID: 8040680
[TBL] [Abstract][Full Text] [Related]
31. Allergy-associated symptoms in relation to childhood non-Hodgkin's as contrasted to Hodgkin's lymphomas: a case-control study in Greece and meta-analysis.
Dikalioti SK; Chang ET; Dessypris N; Papadopoulou C; Skenderis N; Pourtsidis A; Moschovi M; Polychronopoulou S; Athanasiadou-Piperopoulou F; Sidi V; Kalmanti M; Petridou ET
Eur J Cancer; 2012 Aug; 48(12):1860-6. PubMed ID: 22230747
[TBL] [Abstract][Full Text] [Related]
32. Subsequent primary cancers among men and women with in situ and invasive melanoma of the skin.
Balamurugan A; Rees JR; Kosary C; Rim SH; Li J; Stewart SL
J Am Acad Dermatol; 2011 Nov; 65(5 Suppl 1):S69-77. PubMed ID: 22018070
[TBL] [Abstract][Full Text] [Related]
33. Increasing incidence of non-Hodgkin's lymphoma in Karachi, 1995-2002.
Bhurgri Y; Pervez S; Bhurgri A; Faridi N; Usman A; Kazi LA; Ahmed R; Kayani N; Hasan SH
Asian Pac J Cancer Prev; 2005; 6(3):364-9. PubMed ID: 16236001
[TBL] [Abstract][Full Text] [Related]
34. Subsequent malignancies among long-term survivors of Hodgkin lymphoma and non-Hodgkin lymphoma: a pooled analysis of German cancer registry data (1990-2012).
Baras N; Dahm S; Haberland J; Janz M; Emrich K; Kraywinkel K; Salama A
Br J Haematol; 2017 Apr; 177(2):226-242. PubMed ID: 28106907
[TBL] [Abstract][Full Text] [Related]
35. Secondary non-Hodgkin's lymphoma after treatment for childhood cancer.
Eguiguren JM; Ribeiro RC; Pui CH; Hancock ML; Pratt CB; Head DR; Crist WM
Leukemia; 1991 Oct; 5(10):908-11. PubMed ID: 1961025
[TBL] [Abstract][Full Text] [Related]
36. Hodgkin's and non-Hodgkin's lymphomas.
Hartge P; Devesa SS; Fraumeni JF
Cancer Surv; 1994; 19-20():423-53. PubMed ID: 7534635
[TBL] [Abstract][Full Text] [Related]
37. Total registration of non-Hodgkin's lymphoma and Hodgkin's disease in Scotland: effect of deprivation and caseload on outcome.
Ewing JC; White JM; Rattray A; Lessells A; Mackie MJ
Hematology; 2003 Aug; 8(4):211-20. PubMed ID: 12911938
[TBL] [Abstract][Full Text] [Related]
38. Non-Hodgkin's lymphoma among people with AIDS: incidence, presentation and public health burden. AIDS/Cancer Study Group.
Coté TR; Biggar RJ; Rosenberg PS; Devesa SS; Percy C; Yellin FJ; Lemp G; Hardy C; Geodert JJ; Blattner WA
Int J Cancer; 1997 Nov; 73(5):645-50. PubMed ID: 9398040
[TBL] [Abstract][Full Text] [Related]
39. An association between cutaneous melanoma and non-Hodgkin's lymphoma: pooled analysis of published data with a review.
Lens MB; Newton-Bishop JA
Ann Oncol; 2005 Mar; 16(3):460-5. PubMed ID: 15642704
[TBL] [Abstract][Full Text] [Related]
40. The association between malignant melanoma and noncutaneous malignancies.
Wu YH; Kim GH; Wagner JD; Hood AF; Chuang TY
Int J Dermatol; 2006 May; 45(5):529-34. PubMed ID: 16700785
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
